Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Nature Reviews. Cancer|March 25, 2011
PTEN loss in the continuum of common cancers, rare syndromes and mouse modelsM Christine Hollander, Gideon M Blumenthal, Phillip A DennisDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 18, 2003
Activation of the PI3K/Akt pathway and chemotherapeutic resistanceKip A West, S Sianna Castillo, Phillip A DennisCancer Biology & Therapy|February 7, 2004
Targeting aberrant signal transduction pathways in lung cancerJoell J Gills, Courtney A Granville, Phillip A DennisCancer Research|March 23, 2005
Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell deathZhijie Li, Jerry Jaboin, Phillip A Dennis, et al.In Vivo (Athens, Greece)|January 6, 2021
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft TumorsJaclyn Lopiccolo, Shigeru Kawabata, Joell J Gills, et al.Oncotarget|November 21, 2017
Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparibAtsushi Osoegawa, Joell J Gills, Shigeru Kawabata, et al.Journal of the American Chemical Society|January 30, 2003
Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase AktAlan P Kozikowski, Haiying Sun, John Brognard, et al.Molecular Cancer Therapeutics|December 14, 2002
Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cellsAmy S Clark, Kip West, Samantha Streicher, et al.Anti-Cancer Drugs|August 2, 2007
Targeting Akt in cancer therapyJaclyn LoPiccolo, Courtney A Granville, Joell J Gills, et al.Clinical Pharmacology and Therapeutics|June 22, 2020
Relationship Between Progression-Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD-1/PD-L1 Immune Checkpoint Blockade: A Meta-AnalysisJiabu Ye, Xiang Ji, Phillip A Dennis, et al.Pageof 9